Principal Financial Group’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.4M | Buy |
140,883
+14,546
| +12% | +$2M | 0.01% | 860 |
|
|
2025
Q1 | $22.8M | Buy |
126,337
+2,884
| +2% | +$520K | 0.01% | 742 |
|
|
2024
Q4 | $19.3M | Buy |
123,453
+3,727
| +3% | +$584K | 0.01% | 869 |
|
|
2024
Q3 | $21.8M | Sell |
119,726
-3,743
| -3% | -$681K | 0.01% | 789 |
|
|
2024
Q2 | $22.7M | Buy |
123,469
+117,510
| +1,972% | +$21.6M | 0.01% | 774 |
|
|
2024
Q1 | $1.06M | Buy |
5,959
+160
| +3% | +$28.5K | ﹤0.01% | 1861 |
|
|
2023
Q4 | $719K | Buy |
5,799
+31
| +0.5% | +$3.85K | ﹤0.01% | 1882 |
|
|
2023
Q3 | $669K | Sell |
5,768
-125
| -2% | -$14.5K | ﹤0.01% | 1898 |
|
|
2023
Q2 | $692K | Sell |
5,893
-240
| -4% | -$28.2K | ﹤0.01% | 1894 |
|
|
2023
Q1 | $491K | Buy |
6,133
+480
| +8% | +$38.4K | ﹤0.01% | 1967 |
|
|
2022
Q4 | $448K | Buy |
5,653
+264
| +5% | +$20.9K | ﹤0.01% | 2005 |
|
|
2022
Q3 | $376K | Buy |
5,389
+749
| +16% | +$52.3K | ﹤0.01% | 2024 |
|
|
2022
Q2 | $305K | Buy |
+4,640
| New | +$305K | ﹤0.01% | 2173 |
|
|
2021
Q4 | – | Sell |
-4,356
| Closed | -$227K | – | 2587 |
|
|
2021
Q3 | $227K | Sell |
4,356
-704
| -14% | -$36.7K | ﹤0.01% | 2396 |
|
|
2021
Q2 | $344K | Sell |
5,060
-2,523
| -33% | -$172K | ﹤0.01% | 2313 |
|
|
2021
Q1 | $585K | Buy |
7,583
+13
| +0.2% | +$1K | ﹤0.01% | 2115 |
|
|
2020
Q4 | $454K | Buy |
+7,570
| New | +$454K | ﹤0.01% | 2136 |
|